• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血细胞系BaF/3中表达的突变型表皮生长因子受体的生化特性

Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.

作者信息

Walker F, Hibbs M L, Zhang H H, Gonez L J, Burgess A W

机构信息

Ludwig Institute for Cancer Research, Melbourne Tumor Biology Branch, Victoria, Australia.

出版信息

Growth Factors. 1998;16(1):53-67. doi: 10.3109/08977199809017491.

DOI:10.3109/08977199809017491
PMID:9777370
Abstract

The Epidermal Growth Factor (EGF) receptor appears to require a fully active tyrosine kinase domain to transmit mitogenic signals. However, waved-2 mice carrying a mutation in the alpha-helix C of their EGF-R, which abolishes tyrosine kinase activity, only display a mild phenotype and are fully viable. This suggests that the mutant EGF-R signals through heterodimerization with endogenous, kinase active members of the EGF-R family such as ErbB-2 or ErbB-4. We have examined the biochemistry of EGF-Rs carrying mutations in the alpha-helix C of the human EGF-R (V741G and Y740F), in the ATP binding site (K721R) and at the C-terminus (CT957), by expression in BaF/3 cells which are devoid of EGF-R family members. The in vitro kinase activity of the alpha-helix C EGF-R mutants was severely impaired as a result of reduced phosphotransfer activity without appreciable changes in the affinity for either ATP or peptide substrate. Surprisingly, EGF stimulation of cells carrying the different mutant or wild type EGF-Rs resulted in tyrosine phosphorylation of EGF-R proteins; this phosphorylation was abolished in crude plasma membrane preparations, and appears to be due to activation of a membrane-associated or a cytosolic kinase. Receptor-mediated internalization of EGF was profoundly suppressed in the V741G, K721R and CT957 receptor mutant, and high affinity EGF binding was undetectable in the V741G and K721R receptors. We conclude that specific residues in the C-helix of the EGF-R kinase are essential for full kinase activity; mutations in this region do not affect ATP binding, but impair the receptors' phosphotransfer ability. High affinity binding of EGF is not dependent on tyrosine kinase activity or sequences in the C-terminus.

摘要

表皮生长因子(EGF)受体似乎需要一个完全活跃的酪氨酸激酶结构域来传递促有丝分裂信号。然而,携带EGF-R的α螺旋C突变(该突变消除了酪氨酸激酶活性)的waved-2小鼠仅表现出轻微的表型,并且完全可存活。这表明突变的EGF-R通过与EGF-R家族的内源性激酶活性成员(如ErbB-2或ErbB-4)异源二聚化来发出信号。我们通过在缺乏EGF-R家族成员的BaF/3细胞中表达,研究了携带人EGF-R的α螺旋C突变(V741G和Y740F)、ATP结合位点突变(K721R)以及C末端突变(CT957)的EGF-R的生物化学性质。由于磷酸转移活性降低,α螺旋C EGF-R突变体的体外激酶活性严重受损,而对ATP或肽底物的亲和力没有明显变化。令人惊讶的是,用EGF刺激携带不同突变型或野生型EGF-R的细胞会导致EGF-R蛋白的酪氨酸磷酸化;这种磷酸化在粗制质膜制剂中被消除,并且似乎是由于膜相关或胞质激酶的激活。在V741G、K721R和CT957受体突变体中,EGF的受体介导内化被显著抑制,并且在V741G和K721R受体中未检测到高亲和力EGF结合。我们得出结论,EGF-R激酶C螺旋中的特定残基对于完全激酶活性至关重要;该区域的突变不影响ATP结合,但损害受体的磷酸转移能力。EGF的高亲和力结合不依赖于酪氨酸激酶活性或C末端的序列。

相似文献

1
Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.造血细胞系BaF/3中表达的突变型表皮生长因子受体的生化特性
Growth Factors. 1998;16(1):53-67. doi: 10.3109/08977199809017491.
2
Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.激酶缺陷型表皮生长因子受体激活Ras/丝裂原活化蛋白激酶途径可导致细胞存活,但不会导致细胞增殖。
Mol Cell Biol. 1998 Dec;18(12):7192-204. doi: 10.1128/MCB.18.12.7192.
3
Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.表皮生长因子受体的ATP结合位点处的点突变可消除蛋白酪氨酸激酶活性并改变细胞转运。
Cell. 1987 Oct 23;51(2):199-209. doi: 10.1016/0092-8674(87)90147-4.
4
Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a.表皮生长因子与膜运输。表皮生长因子受体内吞作用的激活需要Rab5a。
J Cell Biol. 2000 Oct 30;151(3):539-50. doi: 10.1083/jcb.151.3.539.
5
Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the epidermal growth factor receptor.苏氨酸669和丝氨酸671磷酸化位点的突变去除改变了表皮生长因子受体的底物特异性和配体诱导的内化。
J Biol Chem. 1990 Aug 5;265(22):12820-7.
6
Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation.通过其酪氨酸自身磷酸化的主要羧基末端位点突变改变表皮生长因子受体活性。
J Biol Chem. 1988 Mar 15;263(8):3610-7.
7
Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.表皮生长因子受体胞外部分的结构域缺失会降低配体结合能力,并损害细胞表面表达。
Cell Regul. 1990 Jan;1(2):173-88. doi: 10.1091/mbc.1.2.173.
8
Kinetics of binding, endocytosis, and recycling of EGF receptor mutants.表皮生长因子受体突变体的结合、内吞作用及再循环动力学
J Cell Biol. 1992 Apr;117(1):203-12. doi: 10.1083/jcb.117.1.203.
9
Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase.苏氨酸残基在蛋白激酶C和丝裂原活化蛋白激酶对表皮生长因子受体的调控中的作用。
J Biol Chem. 1993 Jul 25;268(21):15536-43.
10
Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies.
Cell. 1988 Mar 11;52(5):675-84. doi: 10.1016/0092-8674(88)90405-9.

引用本文的文献

1
Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.胶质母细胞瘤衍生的表皮生长因子受体羧基末端缺失突变体具有转化能力,并对 EGFR 靶向治疗敏感。
Cancer Res. 2011 Dec 15;71(24):7587-96. doi: 10.1158/0008-5472.CAN-11-0821. Epub 2011 Oct 14.
2
Co-conserved features associated with cis regulation of ErbB tyrosine kinases.与 ErbB 酪氨酸激酶顺式调控相关的共有保守特征。
PLoS One. 2010 Dec 13;5(12):e14310. doi: 10.1371/journal.pone.0014310.
3
Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.
表皮生长因子受体中配体结合与激酶激活之间的松散连接的结构证据。
Mol Cell Biol. 2010 Nov;30(22):5432-43. doi: 10.1128/MCB.00742-10. Epub 2010 Sep 13.
4
Antibodies specifically targeting a locally misfolded region of tumor associated EGFR.特异性靶向肿瘤相关表皮生长因子受体(EGFR)局部错误折叠区域的抗体。
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5082-7. doi: 10.1073/pnas.0811559106. Epub 2009 Mar 16.
5
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.通过细胞外结构域的新型错义突变激活胶质母细胞瘤中的表皮生长因子受体
PLoS Med. 2006 Dec;3(12):e485. doi: 10.1371/journal.pmed.0030485.
6
Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling.细胞因子信号转导抑制因子(SOCS)-5是表皮生长因子信号转导的潜在负调节因子。
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2328-33. doi: 10.1073/pnas.0409675102. Epub 2005 Feb 3.
7
Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.细胞毒性药物和单克隆抗体806的抗肿瘤疗效通过表皮生长因子受体抑制剂AG1478得到增强。
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15871-6. doi: 10.1073/pnas.2036503100. Epub 2003 Dec 15.
8
Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.激酶缺陷型表皮生长因子受体激活Ras/丝裂原活化蛋白激酶途径可导致细胞存活,但不会导致细胞增殖。
Mol Cell Biol. 1998 Dec;18(12):7192-204. doi: 10.1128/MCB.18.12.7192.